BioStem Technologies Company Description
BioStem Technologies, Inc., a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services.
It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.
The company is also engages in the repackaging and distribution of active pharmaceutical ingredients and other pharmaceutical compounding supplies; and develops and markets nutraceutical products under the Dr.
Dave’s Best and Nesvik Organics brands, as well as other non-proprietary products in the United States and internationally.
The company sells products through e-commerce platforms. BioStem Technologies, Inc. was incorporated in 2006 and is based in Pompano Beach, Florida.
Country | United States |
Founded | 2006 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 33 |
CEO | Jason Matuszewski |
Contact Details
Address: 2836 Center Port Circle Pompano Beach, Florida 33064 United States | |
Phone | 954 380 8342 |
Website | biostemtechnologies.com |
Stock Details
Ticker Symbol | BSEM |
Exchange | OTCMKTS |
Fiscal Year | January - December |
Reporting Currency | USD |
ISIN Number | US0906842002 |
SIC Code | 8731 |
Key Executives
Name | Position |
---|---|
Jason V. Matuszewski | Chief Executive Officer, President, Director and Secretary |
Michael A. Fortunato CPA | Chief Financial Officer |
Andrew Van Vurst CTBS | Chief Operating Officer and Director |
Neal Bhattacharya M.B.A. | Vice President of Marketing |
Dr. David M. Woynarowski | Chief Medical Officer |
Larry Jones | Chief Revenue Officer |
Dr. Irmgard Huber M.D. | International Medical Advisor and Interim Chief Medical Officer |
Shawn F. McCarrey | Chief Commercial Officer |